Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain

  1. Muñoz, A.J.
  2. Ortega, L.
  3. Gutiérrez, A.
  4. Gallardo, E.
  5. Rubio-Rodríguez, D.
  6. Rubio-Terrés, C.
  7. Morón, B.
  8. García-Alfonso, P.
  9. Soria, J.M.
Journal:
Journal of Medical Economics

ISSN: 1941-837X 1369-6998

Year of publication: 2023

Volume: 26

Issue: 1

Pages: 1145-1154

Type: Article

DOI: 10.1080/13696998.2023.2248839 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals